Prevalence of Detectable C-Peptide According to Age at Diagnosis and Duration of Type 1 Diabetes
Prevalence of Detectable C-Peptide According to Age at Diagnosis and Duration of Type 1 Diabetes
复制标题
DOI:
10.2337/dc14-1952
复制
发表时间:
2015-03-01
期刊:
影响因子:
16.2
通讯作者:
Greenbaum, Carla J.
中科院分区:
文献类型:
--
作者:
Davis, Asa K.;DuBose, Stephanie N.;Greenbaum, Carla J.
OBJECTIVEIt is generally accepted that complete beta-cell destruction eventually occurs in individuals with type 1 diabetes, which has implications for treatment approaches and insurance coverage. The frequency of residual insulin secretion in a large cohort of individuals at varying ages of diagnosis and type 1 diabetes duration is unknown.RESEARCH DESIGN AND METHODSThe frequency of residual insulin secretion was determined by measurement of non-fasting serum C-peptide concentration in 919 individuals with type 1 diabetes according to prespecified groups based on age at diagnosis and duration of disease (from 3 to 81 years' duration). Stimulated C-peptide was measured in those with detectable nonfasting values and a group of those with undetectable values as control.RESULTSThe overall frequency of detectable nonfasting C-peptide was 29%, decreasing with time fromdiagnosis regardless of age at diagnosis. In all duration groups, the frequency of C-peptide was higher with diagnosis age >18 years compared with